LU konference
The GAB’s main role is to support the implementation of evidence-based cancer screening programmes at the population level across Europe. It also provides a platform for countries to exchange experiences, learn from each other, and work toward common goals such as improving access, quality, and sustainability in cancer screening.
The two-hour meeting followed a focused agenda that introduced the GAB’s mandate, framework, working methods, and future plans. Members received background on how the GAB fits into EUCanScreen’s overall structure and its expected contributions. Participants discussed which areas of cancer screening governance should be prioritised: legal frameworks, national coordination, funding strategies, and quality assurance systems.
The session also provided an opportunity for countries to highlight what they need most from the project — either technical tools, data, training, or policy advice — and how they plan to advocate for stronger screening policies at home.
One of the key messages from the meeting was that scientific evidence and tools alone are not enough to improve cancer screening. Political support is essential. Screening programmes require long-term planning, adequate funding, legal backing, and coordination between different parts of the health system. These are areas where government involvement is critical, and this is why the GAB was created: to make sure that national authorities are not only informed, but actively involved in shaping and applying EUCanScreen results.
The first meeting of the GAB marks an important step in ensuring that EUCanScreen’s work is translated into real changes in national cancer screening policies and systems.
By bringing together national authorities in one forum, the GAB allows for the exchange of ideas, identification of needs, and coordination of efforts across Europe. With a clear structure, defined purpose, and motivated members, the GAB is now in place to support the political and strategic work needed to make screening programmes more effective and equitable.
 was held on 13th of May 2025. The meeting brought together representatives from national health ministries and authorities across Europe to begin structured collaboration around the governance of cancer screening. GAB is a key element of EUCanScreen, created under Work Package 4 to strengthen the political and strategic engagement of health authorities in the project. It is composed of representatives nominated by ministries of health or similar institutions from each participating country.){kind=link}